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Introduction
During pregnancy and lactation, mammary gland stem cells (MaSCs) and luminal progenitor cells proliferate and differentiate into secretory lobuloalveolar structures under the influence of such hormones as estrogen, progesterone and prolactin [1] . MaSCs are also thought to be the cellular origin of some breast cancer sub-types [2] . Single or multiple exposures to ionizing radiation can uniquely harm healthy cell lines, including stem cells, and trigger mutagenesis [2] [3] [4] [5] [6] [7] [8] [9] . Oncogenesis in humans can occur with acute ionizing radiation doses as low as 10-50 millisieverts (mSv) [1, 10] . Atomic bomb survivors exposed to ionizing radiation before age 40 years were shown to be at higher risk of developing breast cancer, typically with a latency period of about 10 years [11, 12] . Radiotherapy for Hodgkin's disease around the time of pregnancy also may heighten the risk of breast cancer [13] , and is certainly a much higher radiation dose than that from conventional radiodiagnostic procedures.
Pulmonary embolism in pregnancy or the puerperium is a potentially life-threatening condition that requires evaluation using objective testing, such as thoracic computed tomography pulmonary angiography (CTPA) [14] . As thoracic CT focuses a collimated beam of X-rays on the breast region there is a theoretical risk that a woman exposed during pregnancy and lactation could be at accelerated risk of developing breast cancer [15] . However, data are lacking about that risk, and this information is equally important to a radiologist, the requesting physician and a pregnant woman. Accordingly, we determined the short-term risk of developing breast cancer following exposure to thoracic CT during pregnancy or within the early postpartum period.
Methods

Study design
We completed a population-based retrospective cohort study of all women with an obstetrical delivery in Ontario, Canada, where the universal Ontario Health Insurance Plan (OHIP) enables all women to access prenatal and obstetrical care, radiologic testing and cancer screening. Ethical approval was granted by the Sunnybrook Health Sciences Centre Research Ethics Board.
Participants
We included all women aged 16-50 years at the time of an obstetrical delivery of a liveborn or stillborn child at ≥ 20 weeks' gestation, between 1 January 1995 and 31 March 2014 (Table S1 ). We excluded women with any form of cancer diagnosed within 5 years preceding the index delivery date or within 365 days thereafter, or those who died or emigrated out of the province within 365 days of the index delivery date (Fig. 1 ).
Exposures and outcomes
The main study exposure was a thoracic CT during pregnancy or within 42 days postpartum. The start of pregnancy was defined as the delivery date minus the number of gestational weeks at the birth, plus 14 days. We permitted the exposure period to continue up to the conventional 42 days that define the postpartum period, when there remains an abundance of differentiated lobular breast tissue similar to that of late pregnancy [16] .
A woman who requires a CT of the thorax may differ from a woman who does not, in terms of both measured and unmeasured factors. Accordingly, we created an active comparator group who underwent lung ventilationperfusion scintigraphy (VQ) scan, but no thoracic CT scan, in pregnancy or up to 42 days postpartum. If a CT scan and a VQ scan were both performed in the same pregnancy then exposure to thoracic CT was hierarchically assigned. Thus, there were three possible exposure states: thoracic CT, VQ scan only, or neither (the reference group). During the study period, if a woman had more than one delivery, we determined exposure in each pregnancy/postpartum period and allowed exposure status to be updated in a time-varying and non-reversible manner. For instance, a woman could switch from being in the unexposed group at study entry to being in the VQ or CT exposed group in a subsequent pregnancy. Once exposed to thoracic CT, a woman was considered CT exposed for the remainder of her follow-up. The main study outcome was a first diagnosis of breast cancer starting at ≥ 366 days after the index delivery date (time zero) (Table S1 ). Exposure in the index and each subsequent pregnancy was lagged by 365 days to minimize reverse causation, wherein a woman required a CT of the thorax in pregnancy or within 365 days postpartum as part of her work-up for breast cancer. Moreover, starting 1 year after delivery excluded women with pregnancy-associated breast cancer [17] . Women were followed-up until a diagnosis of breast cancer, death, a diagnosis of a non-breast cancer, or the end of the study period (30 June 2016), whichever came first.
Database sources
We used pre-existing linked databases for the entire province of Ontario (Table S1 ), and as described elsewhere [18, 19] . The Canadian Institute for Health Information's (CIHI) Discharge Abstract Database (DAD) comprises all hospital admissions, including obstetrical deliveries, with up to 25 diagnoses (coded using the ICD-9 before 2002, and the ICD-10-CA thereafter). A CT or VQ scan was identified from the OHIP database using the corresponding OHIP billing code(s) assigned for every inpatient or outpatient CT or VQ scan performed in the province (Table S1 ). All cancer diagnoses, including breast cancer (ICD-10 code: C50), were captured in the Ontario Cancer Registry (OCR), including ICD-10 code C50 for breast cancer (Table S1 ). The OHIP Database was also used to identify some covariates captured as an outpatient. The Registered Persons Database, which contains demographic information for all individuals eligible for OHIP, was used to capture all deaths. Diagnosed pulmonary embolism was based on either an inpatient diagnosis or, if an outpatient, the combination of one professional fee code for a related diagnostic imaging test and one diagnostic code for pulmonary embolism, each within 7 days of the other (Table S1 ). Statistics Canada census data were used to classify income quintile and rural status. Information on pre-pregnancy body mass index was available for a subset of deliveries between 2006 and 2011 that could be linked to the Better Outcomes Registry & Network (BORN) Niday dataset. All datasets were linked using unique encoded identifiers and analyzed at the Institute for Clinical Evaluative Sciences (ICES).
Statistical analysis
We used time-dependent multivariable Cox regression models to estimate hazard ratios (HRs) with 95% CIs for incident breast cancer associated with exposure to thoracic CT or VQ scan, relative to exposure to neither. The main model was adjusted for confounders chosen a priori, including maternal age at the index delivery (continuous), as well as time-dependent covariates of year of delivery (continuous), parity (0, 1, ≥ 2), residential income quintile ([Q] 1, 2, 3, 4, 5, unknown), residence (rural, urban, unknown) and preterm birth before 37 weeks' gestation, at the time of the delivery, at which the last exposure status was updated.
The main model was then stratified by the following time-dependent covariates: maternal age (< 35 or ≥ 35 years), parity (nulliparous or parous) and residential income quintile (Q1-2 [lower] or Q3-5 [middle and upper]). Next, the risk of breast cancer was evaluated by the timing of exposure to a thoracic CT or VQ scan, namely, during pregnancy or ≤ 42 days postpartum. We then separately evaluated the risk of breast cancer by staging at the time of diagnosis (stage 0-I or II-IV). We then restricted the sample to women with a minimum of 5 years of total follow-up after the index delivery date, and who were free of any cancer up to 5 years post-index delivery (Additional analysis 1), as well as to women with a maximum of 5 years of total follow-up after the index delivery date (Additional analysis 2).
All statistical analyses were performed using SAS version 9.4 for UNIX (SAS Institute Inc., Cary, NJ, USA).
The minimum required sample size was estimated assuming an incidence rate of breast cancer of 30 per 10 000 person-years [20] , a 0.5% rate of exposure to thoracic CT [20] , and a doubling of the HR of breast cancer following thoracic CT exposure. At a = 0.05 and b = 0.20, the overall required sample size was 1.1 million pregnancies. Nevertheless, the available sample size was fixed at about 1.3 million pregnancies.
Results
Of 1 334 305 women that were initially eligible, 36 980 (2.8%) were excluded ( Fig. 1) . Of those excluded, 3978 (0.3%) had any cancer up to 5 years before or within 1 year after the index delivery, including 220 incident cases of breast cancer within 365 days after birth, the latter equivalent to a 1-year incidence rate of 1.7 per 10 000. Of the 1 297 325 pregnancies included, 5859 were exposed to thoracic CT, for a total of 37 840 person-years; 4075 were exposed to VQ scan, for a total of 31 575 personyears; and 1 292 059 had an unexposed pregnancy, with a total follow-up of 14 342 622 person-years (Table 1) . Of those included and exposed to thoracic CT, 97% of examinations were with intravenous (IV) contrast.
The mean maternal age at delivery was comparable in the exposed and unexposed groups (Table 1) . A greater proportion of women in the thoracic CT group were exposed within 42 days postpartum (66.2%), whereas more women in the VQ scan group were exposed within pregnancy (71.0%); the majority of women had just one diagnostic test (Table 1 ). The overall rate of recognized pulmonary embolism in pregnancy or the postpartum was 15.8% in the thoracic CT group, and 16.0% in the VQ scan group and 0.03% in the unexposed group. The mean Table 1 Characteristics of women exposed to thoracic CT, VQ scan, or neither, during the study period. All data are a number (%), unless otherwise indicated. *When a thoracic CT and a VQ scan were each performed within the same pregnancy, then exposure status was assigned as a thoracic CT. †Pre-pregnancy body mass index was available for a subset of only 102 662 deliveries between 2006 and 2011. ‡More than one test on the same day was counted as one test. §A woman may have had a test in more than one trimester within the same pregnancy. ¶A woman could contribute more than one pregnancy with different exposure states during the study period. In a hierarchical manner, a woman could switch from an unexposed status in one pregnancy to VQ scan-exposed status in a subsequent pregnancy, or from a VQ scan-exposed status to a thoracic CT-exposed status thereafter, but not vice versa. CT, computed tomography; VQ, ventilation perfusion; SD, standard deviation.
(standard deviation [SD]) gestational age at first exposure was 25.6 (10.3) weeks for thoracic CT and 24.5 (9.0) weeks for VQ scan.
Starting from 1 year after index delivery (i.e. time zero), the median duration of follow-up was 5.9 years in the thoracic CT-exposed group, 7.3 years in the VQ scan group and 11.1 years in the unexposed group. There were 10 129 women newly diagnosed with breast cancer during the follow-up period, of whom 9039 (89.2%) were diagnosed by age 50 years. The mean age at diagnosis was 40.6 (5.4) years in the thoracic CT group, 41.9 (5.1) years in the VQ scan group and 43.3 (6.3) years in the unexposed group. The risk of breast cancer associated with exposure by timing of exposure is shown in Table S2 . The broad distribution of breast cancer staging is shown in Table S3 .
For the main model, there were 27 new diagnoses of breast cancer (7.1 per 10 000 person-years) following thoracic CT exposure vs. 10 080 new diagnoses (7.0 per 10 000 person-years) in the unexposed cohort, a crude HR of 1.10 (95% confidence interval [CI], 0.75-1.60) ( Table 2 and Fig. 2) . After multivariable adjustment, the adjusted HR was minimally changed (1.17; 95% CI, 0.80-1.70). Following VQ scan exposure, the incidence rate of breast cancer was 7.0 per 10 000 person-years, and the adjusted HR was 1.23 (95% CI, 0.81-1.87) ( Table 2 and Fig. 2) .
Stratification of the main model by maternal demographic characteristics did not appreciably alter the adjusted HRs, with the exception of VQ scan exposure vs. non-exposure among nulliparous women (adjusted HR, 1.75; 95% CI, 1.01-3.01) (Fig. 3) .
The incidence rate of breast cancer was highest in women exposed to thoracic CT within pregnancy (8.3 per 10 000), with a corresponding adjusted HR of 1.56 (95% CI, 0.84-2.90) compared with the unexposed group (Table 3) . Upon further restricting the exposure period of pregnancy to the second or third trimester, the risk of breast cancer was not evidently higher for thoracic CT (aHR, 1.80; 95% CI, 0.90-3.61) or VQ scan (aHR, 1.52; 95% CI, 0.86-2.68).
In the analysis by breast cancer staging, the adjusted HRs were not significant for thoracic CT or VQ scan exposure in pregnancy or the postpartum (Table S3) . Upon restricting to women with a minimum of 5 years follow-up the results were not appreciably different (Additional analysis 1, Table S4 ). In contrast, among women with less than 5 years of total follow-up, the aHR was 1.72 (95% CI, 0.89-3.31) for thoracic CT, whereas for VQ scan there were too few events, and the results are suppressed (Additional analysis 2, Table S5 ).
Discussion
Within a large population-based study of all births in Ontario between 1995 and 2014, one in 220 were exposed to thoracic CT and one in 318 were exposed to VQ scan during pregnancy or within 42 days postpartum. Neither thoracic CT nor VQ scan were associated with a higher risk of earlyonset breast cancer, including by timing of exposure.
Study strengths and limitations
This study included all eligible women enrolled in a universal healthcare system that provides full access to obstetrical care and medical imaging. The method used herein to ascertain CT and VQ scan exposure, including the timing within pregnancy, was robust, and likely to correctly identify those exposed and those not. However, we did not have information about the exact indication for thoracic CT or VQ scan, although pulmonary embolism was likely to be the reason for most tests.
Given the overall premenopausal age of the women studied herein, we would not expect most women to be screened for breast cancer, so we may have underestimated the risk of breast cancer, especially for disease stage 0-I. Additionally, no data were available about family history of breast cancer or BRCA1 or BRCA2 status, breast feeding, menopausal state [21] or, among those who developed breast cancer, their estrogen-receptor, progesterone-receptor and human epidermal growth factor receptor-2 tumor status. CT, computed tomography; VQ, ventilation perfusion; HR, hazard ratio; CI, confidence interval. *When a thoracic CT and a VQ scan were each performed in the same pregnancy, then exposure status was assigned as a thoracic CT. †Adjusted for age at the baseline delivery (continuous). ‡Adjusted for age at the baseline delivery (continuous) and time-varying parity (0, 1, 2 + ), neighborhood income quintile (1, 2, 3, 4, 5, missing), rural residence (rural, urban, missing), preterm delivery before 37 gestational weeks, and year of delivery (continuous), at the time of delivery of the exposed/unexposed pregnancy.
Starting from 1 year after delivery (i.e., time zero), the median follow-up was 5.9 years in the thoracic CTexposed group, 7.3 years in the VQ scan group and 11.1 years in the unexposed group. Moreover, among pregnant women receiving radiotherapy for Hodgkin's lymphoma, the median time to breast cancer diagnosis was 13.1 years [13] . Also, although we expected the incidence rate of breast cancer to be about 30 per 10 000 person-years [20] , the actual rate was much lower, at 7.0 per 10 000 person-years in the overall unexposed cohort. Only upon limiting the cohort to women followed for fewer than 5 years was the rate closer to 30 per 10 000 person-years (Table S5 ). The shorter duration of surveillance and the relatively young age of our cohorts at maximum follow-up may have resulted in insufficient capture of those breast cancers in development, which might have otherwise been accelerated by exposure to ionizing radiation around the time of pregnancy. Given the wide boundaries of the CIs for the HRs for thoracic CT or VQ scan, there remains a distinct possibility that one or both may heighten the risk of breast cancer. Restricting our sample to women who received a minimum of 5 years follow-up did not appreciably change the results.
Other studies
To the best of our knowledge, no prior controlled studies have evaluated the risk of breast cancer after exposure to thoracic CT or VQ scan, especially around pregnancy, when breast tissue is undergoing proliferation and differentiation [1] . Potential oncogenic effects from ionizing radiation on breast tissue stem from an increased sensitivity of proliferating breast tissue to radiation, but whether there is greater susceptibility in mid-pregnancy or late pregnancy vs. the early postpartum is unknown [15, 22, 23] . One study of atomic bomb blast survivors reported an increased risk of breast cancer among those who also received therapeutic radiation for benign breast disease, such as postpartum mastitis [24] .
Among women exposed to thoracic CT or VQ scan, information was unavailable herein about the radiation dose, either overall, or specifically to the breast. The estimated mean effective radiation dose for CTPA is 7-21 mSv, compared with 0.9-1.29 mSv for VQ scan [25, 26] ; the breast-absorbed doses are 10-44 mGy and 0.11-0.37 mGy, respectively [22, 25, 26] . The dose of radiation is further mitigated by the type of scanner used, the scanning protocol and patient factors, such as percentage of glandular breast tissue [22] . We did not possess information about the specific types of CT scanners used, or the image acquisition protocols applied. Multislice CT (also called multi-detector CT), which gradually made its way into Ontario's hospitals in the early 2000s, can produce higher mean effective radiation doses than the previously used single slice CT [15] . Because 85.2% of thoracic CTs in our study were performed between 2005 and 2014, we can assume that most were multislice CT. Additional analysis 2 was restricted to women with less than 5 years of follow-up (Table S5) , and might be a proxy for capturing the later era of multislice CT imaging. A woman receiving an ionizing radiation dose of 10 mGy from angiographic CT of the chest has an estimated excess lifetime risk of breast cancer of 43 per 10 000 persons [22, 23] . In the current study, 97% of thoracic CTs were with intravenous contrast, probably for the evaluation of suspected pulmonary embolism, especially given the observed rate of pregnancy and postpartum pulmonary embolism of 16% is similar to that seen by some [27] , but three times higher than that noted by others [28] . Despite a higher dose of radiation to the breast with CTPA than with VQ scan, this did not translate into a significantly higher risk of breast cancer, at least within the first few years after exposure. Upon restricting the timing of exposure to pregnancy, while omitting those exposed postpartum, the adjusted HR of breast cancer was still not significantly changed.
We are uncertain about how to interpret the findings of a marginally higher risk of breast cancer in nulliparous women exposed to VQ scan. Nulliparity is a risk factor for breast cancer, whereas breast feeding is protective [29, 30] . VQ scan exposure could have a synergistic effect on breast cancer risk among nulliparous women, but the same would have been expected for thoracic CT. Hence, one should certainly reserve judgment until more data are available.
Clinical implications
Published recommendations about the safety of ionizing radiation in pregnancy and the postpartum have typically focused on the potential teratogenic effects on the fetus, while mentioning the possibility of a higher risk of breast cancer [31] [32] [33] [34] [35] . Although an increased risk of breast cancer following radiological ionizing radiation exposure during pregnancy or lactation has been postulated, this has never been quantified [22] . The current findings help inform those guidelines.
If a thoracic CT or VQ scan is indicated in a woman during pregnancy or lactation, then the non-diagnostic rates of each need to be considered, and CTPA may not be superior to a VQ scan in a woman with a normal chest X-ray [28, 36, 37] . A discussion should also be undertaken about the apparent safety of each [18, 38] . The risk of early-onset breast cancer does not appear to be elevated, although the long-term risk remains unknown.
Conclusions
Exposure to thoracic CT or VQ scan during pregnancy or the postpartum period did not demonstrate any shortterm excess risk of maternal breast cancer. CT, computed tomography; VQ, ventilation perfusion; HR, hazard ratio; CI, confidence interval. *When a thoracic CT and a VQ scan were each performed within the same pregnancy, then exposure status was assigned as thoracic CT. †Adjusted for age at the baseline delivery (continuous) and time-varying parity (0, 1, 2 + ), neighborhood income quintile (1, 2, 3, 4, 5, missing), rural residence (rural, urban, missing), preterm delivery before 37 gestational weeks, and year of delivery (continuous), at the time of delivery of the exposed/unexposed pregnancy.
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